Literature DB >> 16806049

Increased levels of CK19 mRNA in oral squamous cell carcinoma tissue detected by relative quantification with real-time polymerase chain reaction.

Lai-Ping Zhong1, Shi-Fang Zhao, Guan-Fu Chen, Fei-Yun Ping, Ze-Feng Xu, Ji-An Hu.   

Abstract

Oral squamous cell carcinoma (OSCC) is the most common malignant tumour in the oral and maxillofacial region and has a poor prognosis. Cytokeratin 19 (CK19) is a component of cytoskeleton protein. Previous studies have reported abnormal expression of CK19 protein in OSCC tissue. This study is to investigate the quantitative level of CK19 gene transcript in OSCC tissue as well as its clinical significance. Thirty-one OSCC patients (26 males and 5 females) took part in the present study, aged 34-78 years (mean 58.2 years). The level of CK19 mRNA was detected using fluorescent quantitative real-time reverse transcriptase polymerase chain reaction (RT-PCR) in cancerous and paracancerous tissues. The relative quantification in cancerous tissue compared with paracancerous tissue was calculated using the 2(-DeltaDeltaCt) equation. The level of CK19 mRNA in cancerous tissue from OSCC patients was 2.21-fold higher than that in paracancerous tissue (P=0.020), and the amplicon was specific without genomic DNA contamination. The level of CK19 mRNA correlated significantly with the pathological differentiation grade of OSCC tissue (P=0.025), with poorer differentiation indicating a higher level of CK19 mRNA. These results suggest that fluorescent quantitative real-time RT-PCR is accurate and reliable for the detection of CK19 gene transcript levels in OSCC tissue. The level of CK19 mRNA was increased in OSCC tissue, and this was significantly correlated with the pathological differentiation grade.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806049     DOI: 10.1016/j.archoralbio.2006.05.005

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  7 in total

1.  Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions.

Authors:  Ebbing P de Jong; Hongwei Xie; Getiria Onsongo; Matthew D Stone; Xiao-Bing Chen; Joel A Kooren; Eric W Refsland; Robert J Griffin; Frank G Ondrey; Baolin Wu; Chap T Le; Nelson L Rhodus; John V Carlis; Timothy J Griffin
Journal:  PLoS One       Date:  2010-06-17       Impact factor: 3.240

2.  BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma.

Authors:  Anna Guerra; Vincenzo Marotta; Maurilio Deandrea; Manuela Motta; Paolo Piero Limone; Alessia Caleo; Pio Zeppa; Silvano Esposito; Franco Fulciniti; Mario Vitale
Journal:  Endocrine       Date:  2012-12-01       Impact factor: 3.633

3.  Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma.

Authors:  Rewa Malhotra; Aadithya B Urs; Anita Chakravarti; Suman Kumar; V K Gupta; Bhawna Mahajan
Journal:  Tumour Biol       Date:  2016-01-15

4.  Acantholytic squamous cell carcinoma in upper aerodigestive tract: histopathology, immunohistochemical profile and epithelial mesenchymal transition phenotype change.

Authors:  Xin Gu; Ru Jiang; Marjorie R Fowler
Journal:  Head Neck Pathol       Date:  2012-08-01

5.  Colloidal Particles in Tuna Head Soup: Chemical Localization, Structural Change, and Antioxidant Property.

Authors:  Chenchen Ma; Pingping Liu; Ningping Tao; Xichang Wang; Shanggui Deng
Journal:  Front Nutr       Date:  2021-03-29

6.  Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detection.

Authors:  Lili Wang; Yanyan Wang; Yajing Liu; Min Cheng; Xu Wu; Haiming Wei
Journal:  J Exp Clin Cancer Res       Date:  2009-04-28

7.  Immunotherapy for Lewis lung carcinoma utilizing dendritic cells infected with CK19 gene recombinant adenoviral vectors.

Authors:  Q F Sun; X N Zhao; C L Peng; Y T Hao; Y P Zhao; N Jiang; H Xue; J Z Guo; C H Yun; B Cong; X G Zhao
Journal:  Oncol Rep       Date:  2015-08-27       Impact factor: 3.906

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.